Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003223637 | SCV000512221 | uncertain significance | not provided | 2023-04-10 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Invitae | RCV000552703 | SCV000639202 | likely benign | Oligodontia-cancer predisposition syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001027227 | SCV001189745 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-09-05 | criteria provided, single submitter | clinical testing | The c.815+5G>A intronic variant results from a G to A substitution 5 nucleotides after coding exon 1 in the AXIN2 gene. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Sema4, |
RCV001027227 | SCV002537230 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-13 | criteria provided, single submitter | curation |